HomeATXS • NASDAQ
Astria Therapeutics Inc
add
$3.96
0.75%
After Hours:(0.00%)0.00
$3.96
Closed: May 16, 4:38:22 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 37.00M | 53.19% |
Net income | -33.71M | -69.15% |
Net profit margin | — | — |
Earnings per share | -0.58 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 295.06M | -20.23% |
Total assets | 310.39M | -18.06% |
Total liabilities | 21.10M | 90.54% |
Total equity | 289.29M | — |
Shares outstanding | 56.43M | — |
Price to book | 1.16 | — |
Return on assets | -28.34% | — |
Return on capital | -29.88% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -33.71M | -69.15% |
Cash from operations | -34.02M | -78.16% |
Cash from investing | 28.58M | 122.64% |
Cash from financing | — | — |
Net change in cash | -5.44M | -54.49% |
Free cash flow | -22.39M | -74.11% |
Previous close
$3.99
Day range
$3.92 - $4.03
Year range
$3.56 - $12.92
Market cap
223.48M USD
Avg Volume
540.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
78
